Covaxin can be launched as early as February as latest tests on final-stage clinical trials and studies have so far showed it is safe and effective, according to a report."The vaccine has shown good efficacy," senior ICMR scientist Rajni Kant, who is also a member of its COVID-19 task-force, said at the research body's New Delhi headquarters on Thursday, according to Reuters."It is expected that by the beginning of next year, February or March, something would be available," he told Reuters.
Bharat Biotech, a private company that is developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), had earlier hoped to launch it only in the second quarter of next year.Here are the key updates on trials, efficacy of.